July 9, 2026 · Form 4 insider transaction
Dykan Jeff bought 12,500 shares of Regentis Biomaterials Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026.; The warrants are currently exercisable and have a three year term.